Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Aptamer-based Targeted Delivery of a G-quadruplex Ligand in Cervical Cancer Cells

J. Carvalho, A. Paiva, MP. Cabral Campello, A. Paulo, JL. Mergny, GF. Salgado, JA. Queiroz, C. Cruz,

. 2019 ; 9 (1) : 7945. [pub] 20190528

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc20028901

AS1411 is a G-rich DNA oligonucleotide that functions as an aptamer of the protein nucleolin, found at high levels on the surface of cancer cells but not on the surface of normal cells. Herein, we have studied AS1411 as a supramolecular carrier for the delivery of an acridine-based G-quadruplex ligand, C8, to HeLa cancer cells. Two AS1411 derivatives, LNA-AS1411 and U-AS1411, were also tested, in an attempt to compare AS1411 pharmacological properties. The results showed that AS1411-C8 complexation was made with great binding strength and that it lowered the ligand's cytotoxicity towards non-malignant cells. This effect was suggested to be due to a decreased internalization of the complexed versus free C8 as shown by flow cytometry. The AS1411 derivatives, despite forming a stable complex with C8, lacked the necessary tumour-selective behaviour. The binding of C8 to AS1411 G-quadruplex structure did not negatively affect the recognition of nucleolin by the aptamer. The AS1411-C8 repressed c-MYC expression at the transcriptional level, possibly due to C8 ability to stabilize the c-MYC promoter G-quadruplexes. Overall, this study demonstrates the usefulness of AS1411 as a supramolecular carrier of the G-quadruplex binder C8 and the potential of using its tumour-selective properties for the delivery of ligands for cancer therapy.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20028901
003      
CZ-PrNML
005      
20210114155313.0
007      
ta
008      
210105s2019 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41598-019-44388-9 $2 doi
035    __
$a (PubMed)31138870
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Carvalho, Josué $u CICS-UBI - Centro de Investigação em Ciências da Saúde, Universidade da Beira Interior, Av. Infante D. Henrique, 6200-506, Covilhã, Portugal.
245    10
$a Aptamer-based Targeted Delivery of a G-quadruplex Ligand in Cervical Cancer Cells / $c J. Carvalho, A. Paiva, MP. Cabral Campello, A. Paulo, JL. Mergny, GF. Salgado, JA. Queiroz, C. Cruz,
520    9_
$a AS1411 is a G-rich DNA oligonucleotide that functions as an aptamer of the protein nucleolin, found at high levels on the surface of cancer cells but not on the surface of normal cells. Herein, we have studied AS1411 as a supramolecular carrier for the delivery of an acridine-based G-quadruplex ligand, C8, to HeLa cancer cells. Two AS1411 derivatives, LNA-AS1411 and U-AS1411, were also tested, in an attempt to compare AS1411 pharmacological properties. The results showed that AS1411-C8 complexation was made with great binding strength and that it lowered the ligand's cytotoxicity towards non-malignant cells. This effect was suggested to be due to a decreased internalization of the complexed versus free C8 as shown by flow cytometry. The AS1411 derivatives, despite forming a stable complex with C8, lacked the necessary tumour-selective behaviour. The binding of C8 to AS1411 G-quadruplex structure did not negatively affect the recognition of nucleolin by the aptamer. The AS1411-C8 repressed c-MYC expression at the transcriptional level, possibly due to C8 ability to stabilize the c-MYC promoter G-quadruplexes. Overall, this study demonstrates the usefulness of AS1411 as a supramolecular carrier of the G-quadruplex binder C8 and the potential of using its tumour-selective properties for the delivery of ligands for cancer therapy.
650    _2
$a buňky A549 $7 D000072283
650    _2
$a protinádorové látky $x metabolismus $x farmakologie $7 D000970
650    _2
$a aptamery nukleotidové $x metabolismus $x farmakologie $7 D052157
650    _2
$a buněčné linie $7 D002460
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a viabilita buněk $x účinky léků $7 D002470
650    _2
$a fibroblasty $x cytologie $x účinky léků $x metabolismus $7 D005347
650    12
$a G-kvadruplexy $7 D054856
650    12
$a regulace genové exprese u nádorů $7 D015972
650    _2
$a technika přenosu genů $7 D018014
650    _2
$a HeLa buňky $7 D006367
650    _2
$a lidé $7 D006801
650    _2
$a ligandy $7 D008024
650    _2
$a oligodeoxyribonukleotidy $x metabolismus $x farmakologie $7 D009838
650    _2
$a orgánová specificita $7 D009928
650    _2
$a fosfoproteiny $x antagonisté a inhibitory $x genetika $x metabolismus $7 D010750
650    _2
$a promotorové oblasti (genetika) $7 D011401
650    _2
$a vazba proteinů $7 D011485
650    _2
$a protoonkogenní proteiny c-myc $x genetika $x metabolismus $7 D016271
650    _2
$a proteiny vázající RNA $x antagonisté a inhibitory $x genetika $x metabolismus $7 D016601
650    _2
$a genetická transkripce $7 D014158
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Paiva, Artur $u Unidade de Gestão Operacional em Citometria, Centro Hospitalar e Universitário de Coimbra (CHUC), Coimbra, Portugal. CIMAGO/iCBR/CIBB, Faculdade de Medicina da Universidade de Coimbra, Coimbra, Portugal. Instituto Politécnico de Coimbra, ESTESC-Coimbra Health School, Ciências Biomédicas Laboratoriais, Coimbra, Portugal.
700    1_
$a Cabral Campello, Maria Paula $u Centro de Ciências e Tecnologias Nucleares, Instituto Superior Técnico, Universidade de Lisboa, Estrada Nacional 10 (km 139,7), 2695-066, Bobadela, LRS, Portugal.
700    1_
$a Paulo, António $u Centro de Ciências e Tecnologias Nucleares, Instituto Superior Técnico, Universidade de Lisboa, Estrada Nacional 10 (km 139,7), 2695-066, Bobadela, LRS, Portugal.
700    1_
$a Mergny, Jean-Louis $u Univ. Bordeaux, ARNA laboratory, INSERM, U1212, CNRS UMR 5320, IECB, F-33600, Pessac, France. Institute of Biophysics, AS CR, v.v.i. Kralovopolska 135, 612 65, Brno, Czech Republic.
700    1_
$a Salgado, Gilmar F $u Univ. Bordeaux, ARNA laboratory, INSERM, U1212, CNRS UMR 5320, IECB, F-33600, Pessac, France.
700    1_
$a Queiroz, João A $u CICS-UBI - Centro de Investigação em Ciências da Saúde, Universidade da Beira Interior, Av. Infante D. Henrique, 6200-506, Covilhã, Portugal.
700    1_
$a Cruz, Carla $u CICS-UBI - Centro de Investigação em Ciências da Saúde, Universidade da Beira Interior, Av. Infante D. Henrique, 6200-506, Covilhã, Portugal. carlacruz@fcsaude.ubi.pt.
773    0_
$w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 9, č. 1 (2019), s. 7945
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31138870 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20210105 $b ABA008
991    __
$a 20210114155311 $b ABA008
999    __
$a ok $b bmc $g 1609236 $s 1120081
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 9 $c 1 $d 7945 $e 20190528 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195
LZP    __
$a Pubmed-20210105

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...